Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Strides Arcolab Ltd to acquire majority stake of Bafna Pharmaceuticals Ltd's generics business-Business Standard


Monday, 21 Jul 2014 08:06am EDT 

Strides Arcolab Ltd:Entered into an agreement with Bafna Pharmaceuticals to acquire majority stake of their India Branded generics business for a cash consideration of 480 mln Indian Rupees-Business Standard. 

Company Quote

714.25
14.6 +2.09%
30 Sep 2014